Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride | Patent Number 08236804

US 08236804 B2
Application Number13100948
Publication NumberUS 20110294825 A1
Pendency1 year, 3 months, 6 days
Filled DateMay 4, 2011
Priority DateJun 5, 2002
Publication DateDec 1, 2011
Expiration DateJun 5, 2022
Inventor/ApplicantsSteffen Neuenfeld
Heike Kniel
Susanne Rudolph
Matthias Bartels
Bernd Helfert
Andreas Bathe
Henning Böttcher
ExaminesCHUNG, SUSANNAH LEE
Art Unit1626
Technology Center1600
Assignments
Merck Patentgesellschaft
Current
Merck PatentgesellschaftMerck & Co. Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.